| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D223D0012 | Quetiapine Fumarate XR Tablets | |
| Synopsis | ||
|
Quetiapine Fumarate XR Tablets .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY | AWARD Notice | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D223D0012 | Quetiapine Fumarate XR Tablets | |
| Synopsis | ||
|
Modification SPE2D223D0012 P00001 to change the price effective date from December 17, 2023 to October 18, 2023. Modification SPE2D223D0012 P00001 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Award SPE2D223D0012 Quetiapine Fumarate XR Tablets .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY | AWARD Notice | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| SPE2D223D0012 | Quetiapine Fumarate XR Tablets | |
| Synopsis | ||
|
Modification SPE2D223D0012 P00001 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Award SPE2D223D0012 Quetiapine Fumarate XR Tablets .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE LOGISTICS AGENCY (DLA) | AWARD Notice | |